MedPath

Doxazosin

DOXAZOSIN TABLETS USPRx only

Approved
Approval ID

426f6918-7705-4988-a875-823196f43859

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 20, 2011

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Doxazosin Mesylate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code42254-075
Application NumberANDA075536
Product Classification
M
Marketing Category
C73584
G
Generic Name
Doxazosin Mesylate
Product Specifications
Route of AdministrationORAL
Effective DateAugust 7, 2009
FDA Product Classification

INGREDIENTS (7)

DOXAZOSIN MESYLATEActive
Quantity: 2 mg in 1 1
Code: 86P6PQK0MU
Classification: ACTIM
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Doxazosin - FDA Drug Approval Details